AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Oct 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-09-30

Reporting Person: Barth Jay (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-30	Common Stock	M	4064	$2.29	Acquired	167268	Direct
2020-09-30	Common Stock	S	4064	$14.5057	Disposed	163204	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-30	Stock Options (right to buy)	$2.29	M	4064	Disposed	2024-03-03	Common Stock (4064)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: All of the options were fully vested and exercisable as of the transaction date.